Moment Of Truth For Belantamab Mafodotin, Trikafta And Turalio At EMA

 
• By Neena Brizmohun

A number of drug companies are set to learn the fate of their marketing authorization applications in the EU this week.

Wooden_Signpost
The EMA is deciding whether to recommend approval for a number of drugs • Source: Shutterstock

More from Product Reviews

More from Pink Sheet